Clinical trial
Proof of Concept Study of the Safety and Immunogenicity of Influenza Virus Vaccine Fluzone® 2004-2005 Among Healthy Children 2 Months vs 6 Months of Age
NCT00858468 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Proof of Concept Study of the Safety and Immunogenicity of Influenza Virus Vaccine Fluzone® 2004-2005 Among Healthy Children 2 Months vs 6 Months of Age
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- December 31, 2006
- Enrollment
- 394 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
influenza